TRILLIUM THERAPEUTICS INC. Comprehensive Income
TRILLIUM THERAPEUTICS INC. reported Comprehensive Income of -$19.30 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2021-11-12
- TRILLIUM THERAPEUTICS INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-09-30 was -$19.30M.
- TRILLIUM THERAPEUTICS INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-06-30 was -$18.56M.
- TRILLIUM THERAPEUTICS INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2021-03-31 was -$10.86M.
- TRILLIUM THERAPEUTICS INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2020-12-31 was -$7.32M.
- TRILLIUM THERAPEUTICS INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$59.35M.
- TRILLIUM THERAPEUTICS INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2019 was -$37.67M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$19.30M 10-Q · filed 2021-11-12 | -$37.86M derived: sum of 2 quarters · filed 2021-11-12 | -$48.72M 10-Q · filed 2021-11-12 | -$56.05M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | -$18.56M 10-Q · filed 2021-08-13 | -$29.42M 10-Q · filed 2021-08-13 | -$36.75M derived: sum of 3 quarters · filed 2021-08-13 | -$49.25M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-03-31 | -$10.86M 10-Q · filed 2021-05-07 | -$18.18M derived: sum of 2 quarters · filed 2021-05-07 | -$30.69M derived: sum of 3 quarters · filed 2021-11-12 | -$53.91M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-12-31 | -$7.32M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$19.83M derived: sum of 2 quarters · filed 2021-11-12 | -$43.05M derived: sum of 3 quarters · filed 2021-11-12 | -$59.35M 10-K · filed 2021-03-18 |
| 2020-09-30 | -$12.51M 10-Q · filed 2021-11-12 | -$35.73M derived: sum of 2 quarters · filed 2021-11-12 | -$52.02M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$23.22M 10-Q · filed 2021-08-13 | -$39.52M 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | -$16.30M 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | -$37.67M 10-K · filed 2021-03-18 |